These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11532580)

  • 1. PLGA microparticles: possible vehicles for topical drug delivery.
    de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
    Int J Pharm; 2001 Sep; 226(1-2):181-4. PubMed ID: 11532580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of topical cidofovir penetration using microparticles.
    Santoyo S; Ga de Jalón E; Ygartua P; Renedo MJ; Blanco-Príeto MJ
    Int J Pharm; 2002 Aug; 242(1-2):107-13. PubMed ID: 12176232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
    de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
    J Control Release; 2001 Jul; 75(1-2):191-7. PubMed ID: 11451509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein instability in poly(lactic-co-glycolic acid) microparticles.
    van de Weert M; Hennink WE; Jiskoot W
    Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.
    Haddadi A; Aboofazeli R; Erfan M; Farboud ES
    J Microencapsul; 2008 Sep; 25(6):379-86. PubMed ID: 18465299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen.
    Batanero E; Barral P; Villalba M; Rodríguez R
    J Immunol Methods; 2002 Jan; 259(1-2):87-94. PubMed ID: 11730844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porous biodegradable microparticles for delivery of pentamidine.
    Mandal TK; Bostanian LA; Graves RA; Chapman SR; Idodo TU
    Eur J Pharm Biopharm; 2001 Jul; 52(1):91-6. PubMed ID: 11438428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
    Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
    Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system.
    Seemann S; Hauff P; Schultze-Mosgau M; Lehmann C; Reszka R
    Pharm Res; 2002 Mar; 19(3):250-7. PubMed ID: 11934230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biocompatibility of the PLGA microparticles in parotid gland.
    Cantín M; Miranda P; Suazo Galdames I; Zavando D; Arenas P; Velásquez L; Vilos C
    Int J Clin Exp Pathol; 2013; 6(11):2412-8. PubMed ID: 24228103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular microparticles for drug delivery to the TMJ.
    Mountziaris PM; Sing DC; Mikos AG; Kramer PR
    J Dent Res; 2010 Oct; 89(10):1039-44. PubMed ID: 20660799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKK2 inhibition using TPCA-1-loaded PLGA microparticles attenuates laser-induced choroidal neovascularization and macrophage recruitment.
    Gaddipati S; Lu Q; Kasetti RB; Miller MC; Lu Q; Trent JO; Kaplan HJ; Li Q
    PLoS One; 2015; 10(3):e0121185. PubMed ID: 25803615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.
    Singh M; Carlson JR; Briones M; Ugozzoli M; Kazzaz J; Barackman J; Ott G; O'Hagan D
    Vaccine; 1998 Nov; 16(19):1822-7. PubMed ID: 9795387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.
    Zidan AS; Sammour OA; Hammad MA; Megrab NA; Hussain MD; Khan MA; Habib MJ
    AAPS PharmSciTech; 2006 Jul; 7(3):61. PubMed ID: 17025242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.